Correlation Between Eli Lilly and IQVIA Holdings

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eli Lilly and IQVIA Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eli Lilly and IQVIA Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eli Lilly and and IQVIA Holdings, you can compare the effects of market volatilities on Eli Lilly and IQVIA Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eli Lilly with a short position of IQVIA Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eli Lilly and IQVIA Holdings.

Diversification Opportunities for Eli Lilly and IQVIA Holdings

0.91
  Correlation Coefficient

Almost no diversification

The 3 months correlation between Eli and IQVIA is 0.91. Overlapping area represents the amount of risk that can be diversified away by holding Eli Lilly and and IQVIA Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on IQVIA Holdings and Eli Lilly is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eli Lilly and are associated (or correlated) with IQVIA Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of IQVIA Holdings has no effect on the direction of Eli Lilly i.e., Eli Lilly and IQVIA Holdings go up and down completely randomly.

Pair Corralation between Eli Lilly and IQVIA Holdings

Considering the 90-day investment horizon Eli Lilly and is expected to generate 1.02 times more return on investment than IQVIA Holdings. However, Eli Lilly is 1.02 times more volatile than IQVIA Holdings. It trades about -0.15 of its potential returns per unit of risk. IQVIA Holdings is currently generating about -0.17 per unit of risk. If you would invest  95,495  in Eli Lilly and on August 31, 2024 and sell it today you would lose (16,676) from holding Eli Lilly and or give up 17.46% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy100.0%
ValuesDaily Returns

Eli Lilly and  vs.  IQVIA Holdings

 Performance 
       Timeline  
Eli Lilly 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eli Lilly and has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's essential indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
IQVIA Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days IQVIA Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Eli Lilly and IQVIA Holdings Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eli Lilly and IQVIA Holdings

The main advantage of trading using opposite Eli Lilly and IQVIA Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eli Lilly position performs unexpectedly, IQVIA Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IQVIA Holdings will offset losses from the drop in IQVIA Holdings' long position.
The idea behind Eli Lilly and and IQVIA Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Stocks Directory
Find actively traded stocks across global markets
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon